Navigation Links
Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy
Date:12/4/2008

MONTPELLIER, France, Dec. 4 /PRNewswire-FirstCall/ -- A 60-year-old prostate cancer patient from Montpellier has become the first person in France to be treated using RapidArc(TM) technology from Varian Medical Systems (NYSE: VAR) for fast and precise forms of intensity modulated radiotherapy (IMRT). Each of his treatments at the CRLC Val D'Aurelle - Paul Lamarque in the city took just 75 seconds, several times faster than conventional IMRT treatments. Dr. Pascal Fenoglietto, the hospital's chief medical physicist for scientific projects, presented the case to colleagues at the annual meeting of the French Society of Radiation Oncologists (SFRO) in Paris from November 12- 14.

"The treatments went extremely well and the patient was very pleased because compared to conventional IMRT it was three times quicker," Dr. Fenoglietto said. "We are now able to use the time we save on treatment delivery to take more images and increase the quality of our care."

"The radiation therapists were also very pleased because it is a simpler treatment for them to deliver," added Professor Jean-Bernard Dubois, head of the radiation oncology department and managing director of the hospital.

With RapidArc, Varian's Clinac(R) medical linear accelerator can target radiation beams at a tumor while making one continuous rotation around the patient. Conventional IMRT treatments are slower and more difficult for radiotherapy radiographers because they target tumors using a complex sequence of fixed beams from multiple angles.

RapidArc technology allows more control to conform the dose more closely to the size, shape, and location of the tumor. Faster treatment also contributes to precision by reducing the time for motion within the anatomy, and laboratory studies suggest that faster dose delivery kills cancer cells more e
'/>"/>

SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
2. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
3. Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial
4. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
5. Center for Molecular Medicine Among First to Offer New FDA-Approved Test to Aid in Treatment of Prostate Cancer
6. CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal
7. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
8. ProMetic presents preclinical data for prostate and pancreatic cancer at the AACR Meeting
9. New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor
10. When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer
11. American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
(Date:12/15/2014)... YORK , Dec. 15, 2014  GlassesOff Inc. ... Yuval Bar-Gil as an independent director of the ... founder of AeroScout and served as its CEO until ... in 2012, a $240 million transaction. Recognized as the ... Mr. Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID solutions ...
(Date:12/13/2014)... Clarassance, a privately held clinical-stage biotechnology company ... Therabron Therapeutics , Inc. The new name is derived ... structure in the lungs similar to branches on a ... protein therapeutics for the treatment of respiratory diseases. ... name to mark the company's escalation into the clinical ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Wis. - A Milwaukee-area producer of brain imaging ... expand its market share, and it did not have ... a company specializing in functional magnetic resonance imaging (fMRI) ... Racine-based Ad-Tech Medical Instrument Co. to promote ...
... - Metavante Co. , the banking and payments ... has announced licensing of online loan software to the ... move, ING Bank, with more than four million customers ... package of lending products for its wholesale mortgage operation, ...
... put on by SkyPilot Networks at Hamburger University in Oak ... statements to rally municipal attendees. He said we need to ... a difference. , ,Quinn had some encouraging remarks about keeping ... or economic blockading. He has made this a priority in ...
Cached Biology Technology:Municipal broadband in Illinois: Where are the standards? 2Municipal broadband in Illinois: Where are the standards? 3Municipal broadband in Illinois: Where are the standards? 4
(Date:11/18/2014)... Nov. 17, 2014   News ... collaborate to develop The Partners Data Lake, an ... Partners Data Lake will allow researcher and clinicians ... treatment and the lives of patients , ... clinical activities across the Partners system, breaking down ...
(Date:11/12/2014)... 12, 2014 Crossmatch™, a leading provider of ... ® fingerprint readers have been deployed throughout Montparnasse ... Central Mexico . The bakery chain implemented the ... issues caused by employees clocking in for each other. ... readers, Montparnasse relied on paper timecards and a mechanical ...
(Date:11/7/2014)... 7, 2014  In conjunction with the Glendale ... The Community Foundation of the Verdugos has announced the " ... PROJECT," a $250,000 initiative to keep the Verdugo Regional Crime ... first six months of existence, the Lab has processed more ... local law enforcement. "Because our number one priority ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2
... Department of Energy,s Argonne National Laboratory is working ... the goal of creating a cleaner Beijing and ... and beyond. Recently, DOE and China,s ... agreement aimed at promoting large scale deployment of ...
... 2007 Keck Graduate Institute (KGI) today announced that Dr. ... has published a paper in the international online journal ... of moveable genetic elements, or jumping genes. We have ... one place to another within the genome, said President Sheldon ...
... A study by an Indiana University environmental science professor ... genetically engineered corn has the potential to harm aquatic ... by the journal Proceedings of the National Academies ... Royer, an assistant professor in the IU School of ...
Cached Biology News:Argonne helps China create cleaner Beijing for 2008 Olympics 2KGI professor contributes new insights on 'jumping genes' 2Study shows genetically engineered corn could affect aquatic ecosystems 2Study shows genetically engineered corn could affect aquatic ecosystems 3
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
...
Mouse monoclonal antibody to UGT2B10 - UDP glucuronosyltransferase 2 family, polypeptide B10...
Biology Products: